Welcome to Cytomyx Holdings Plc

		Cytomyx Holdings plc (AIM:CYX) is a rapidly growing life science company which provides a range of human tissue based biomarker discovery and validation solutions to the bio-pharmaceutical research market to enhance their drug discovery productivity. Cytomyx solutions enable clients to make better-informed decisions during drug development, through enhanced understanding of the role of gene and protein targets in disease progression and by being able to predict and eliminate drug candidates which might otherwise fail in late-stage development due to issues of toxicity or poor efficacy company. Cytomyx LLC, the core business unit of Cytomyx Holdings Plc, is uniquely positioned as a potential leader in the field of biomarker discovery and validation. The company has collected over 200,000 clinically important human tissue samples over the years and works with many customers who rely on Cytomyx' tissue repository and clinical data for biomarker discovery and validation. Cytomyx was formed in 1996 and is publicly listed on London's Alternative Investment Market. Disclaimer
Link to the products and services website

	Cytomyx LLC launches Biomarker Discovery Tools